Adding neoadjuvant anastrozole to trastuzumab deruxtecan in HER2-low breast cancer Presented ByDr Sarah Hurvitz , UCLA Jonsson Comprehensive Cancer Center TrialPhase 2, TALENT JournalPhysician's Weekly ConferenceASCO 2021 6 August, 2021 12:34
Anastrozole yields long term effects in the prevention of breast cancer occurrence TrialIBIS-II ConferenceSABCS 2019 13 February, 2020 23:47